“Glucagon Like Peptide (Glp – 1) Receptor: A Promising Therapeutic Target for Screening of Herbal Antidiabetic Compounds”, AJP, vol. 12, no. 02, Aug. 2018, doi: 10.22377/ajp.v12i02.2384.